Skip to main content
LIGAND PHARMACEUTICALS INC logo

LIGAND PHARMACEUTICALS INC — Investor Relations & Filings

Ticker · LGND ISIN · US53220K5048 LEI · 5493008K7TB0IKP37H79 US Financial and insurance activities
Filings indexed 1,392 across all filing types
Latest filing 2016-03-03 Regulatory Filings
Country US United States of America
Listing US LGND

About LIGAND PHARMACEUTICALS INC

https://www.ligand.com/

Ligand Pharmaceuticals Incorporated is a biopharmaceutical company that functions as a capital and technology partner to the life sciences industry. The company's business model focuses on acquiring and developing royalty-generating assets by investing in the clinical development and commercialization of medicines. It manages a large, diverse portfolio of economic rights to partnered programs across therapeutic areas such as oncology, kidney disease, diabetes, and rare conditions. In addition to its royalty business, Ligand develops and licenses its proprietary technology platforms to a global network of biopharmaceutical partners. Its key technologies include Captisol®, a chemically modified cyclodextrin used to improve the solubility and stability of active pharmaceutical ingredients, and the NITRICIL™ platform.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K/A, which is an amendment to a previously filed Form 8-K. It is a current report filed pursuant to the Securities Exchange Act of 1934. The content focuses on refiling an exhibit (a License Agreement) that was previously redacted for confidential treatment. There is no financial data, earnings information, or detailed report content. The document is primarily an amendment to a regulatory filing to update or correct previously filed information. It does not contain a full annual or quarterly report, audit report, or other detailed financial disclosures. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2016-03-03 English
10-K
Annual Report FY 2015
2016-02-26 English
PRIMARY DOCUMENT
Director's Dealing
2016-02-17 English
PRIMARY DOCUMENT
Director's Dealing
2016-02-17 English
PRIMARY DOCUMENT
Director's Dealing
2016-02-17 English
PRIMARY DOCUMENT
Director's Dealing
2016-02-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.